# Clinical Evaluation of the Xpert® HIV-1 VL

> **NCT02461576** · — · COMPLETED · sponsor: **Cepheid** · enrollment: 966 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DEVICE:** Xpert HIV-1 VL Assay

## Key facts

- **NCT ID:** NCT02461576
- **Lead sponsor:** Cepheid
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2017-02-24
- **Final completion:** 2017-02-24
- **Target enrollment:** 966 (ACTUAL)
- **Last updated:** 2018-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02461576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02461576, "Clinical Evaluation of the Xpert® HIV-1 VL". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02461576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*